Guilin Sanjin Pharmaceutical Co., Ltd.
002275.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.26B
Close$
Share Statistics
| Market cap | $7.26 Billion |
|---|---|
| Enterprise Value | $6.88 Billion |
| Dividend Yield | $0.50 (4.05%) |
| Earnings per Share | $0.74 |
| Beta | 0.21 |
| Outstanding Shares | 587,568,600 |
Return
| Return on Equity | 12.47% |
|---|---|
| Return on Assets | 10.07% |
| Return on Invested Capital | 15.81% |
Valuation & Multiples
| P/E Ratio | 17.86 |
|---|---|
| PEG | -71.14 |
| Price to Sales | 4.1 |
| Price to Book Ratio | 2.46 |
| Enterprise Value to Revenue | 3.41 |
| Enterprise Value to EBIT | 12.06 |
| Enterprise Value to Net Income | 16 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 21, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Guilin Sanjin Pharmaceutical Co., Ltd.
2,563 employees
CEO: Xun Zou Guilin Sanjin Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm dedicated to the research, production, and distribution of traditional Chinese and natural medicines across China. Established in 1967 and headquartered in Guilin, t...